SCHAERR JAFFE LLP

Lobbying for CELLPHIRE THERAPEUTICS, INC. · biotechnology company

Filing Registration

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Jul 25, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Maryland

Lobbying activity 2

Health Issues

Increasing and improving the nation's blood platelet supply.

Disaster Planning/Emergencies

Increasing and improving the nation's blood platelet supply.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.